Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 25;11(5):e0146623.
doi: 10.1128/spectrum.01466-23. Online ahead of print.

Anti-inflammatory effects of yeast-derived vacuoles on LPS-induced murine macrophage activation

Affiliations

Anti-inflammatory effects of yeast-derived vacuoles on LPS-induced murine macrophage activation

Su-Min Lee et al. Microbiol Spectr. .

Abstract

Saccharomyces cerevisiae is a single-celled fungal microorganism. S. cerevisiae-derived vacuoles are closely related to mammalian lysosomes, which play a role in the degradation of macromolecules by various hydrolytic enzymes. This study evaluated the anti-inflammatory efficacy of S. cerevisiae-vacuoles by inhibiting inflammatory mediators induced by lipopolysaccharide (LPS). The results showed that treatment with 5, 10, and 20 µg/mL of S. cerevisiae-derived vacuoles almost completely inhibited the LPS-induced expression of iNOS protein and mRNA. Moreover, vacuoles significantly reduced the mRNA expression of tumor necrosis factor alpha (TNF-α), interleukin 1 beta (IL-1β), and interleukin 6 (IL-6) in LPS-stimulated macrophages compared to the control cells. The immunofluorescence analysis confirmed that S. cerevisiae-derived vacuoles inhibited the translocation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) in LPS-stimulated cells. Taken together, the treatment with S. cerevisiae-derived vacuoles alone activated macrophages, but LPS-activated macrophages modulated pro-inflammatory mediators by downregulating the NF-κB pathway. These results suggest that S. cerevisiae-derived vacuoles may have therapeutic potential in the treatment of inflammatory diseases. In conclusion, our study provides new insights into the immunomodulatory effects of S. cerevisiae-derived vacuoles and their potential as a novel anti-inflammatory agent. IMPORTANCE This study investigates the potential of using vacuoles derived from the yeast Saccharomyces cerevisiae as a new anti-inflammatory therapy. Inflammation is a natural response of the immune system to invading pathogens, but when it is dysregulated, it can lead to chronic diseases. The researchers found that treating macrophages with vacuoles significantly reduced the production of pro-inflammatory cytokines and iNOS, markers of inflammation when they were stimulated with lipopolysaccharide. The study also showed that vacuoles inhibited the NF-κB signaling pathway, which is involved in the induction of pro-inflammatory cytokines in macrophages. These findings suggest that S. cerevisiae-derived vacuoles may have potential as a new therapeutic agent for regulating the inflammatory response in various diseases. Further studies are needed to evaluate the efficacy and safety of vacuoles in vivo and to elucidate the underlying mechanisms of their anti-inflammatory effects.

Keywords: S. cerevisiae-derived vacuole; anti-inflammatory; lipopolysaccharide; macrophage.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
Characterization of S. cerevisiae-derived vacuoles. (A) Bio-TEM images of the S. cerevisiae-derived vacuoles. (B) FE-SEM images of the vacuoles. (C) Size distribution curve of the vacuoles analyzed by NTA.
Fig 2
Fig 2
Effect of S. cerevisiae-derived vacuoles on the expression of iNOS in LPS-stimulated RAW 264.7 cells. (A) The cells were stimulated with 1 µg/mL LPS for 2 hours at the indicated doses, treated with dexamethasone or vacuoles for 22 hours, and then assessed for iNOS protein using Western blot analysis. (B) The relative ratio of iNOS to β-actin was determined using densitometry, with LPS being employed as a control.
Fig 3
Fig 3
S. cerevisiae-derived vacuoles inhibit LPS-induced pro-inflammatory cytokines such as (A) TNF-α and (B) IL-6 protein production. (C) S. cerevisiae-derived vacuole enzyme and pellet components change TNF-α cytokine production. Cells were stimulated with 1 µg/mL LPS at the indicated doses for 2 hours, treated with dexamethasone or vacuoles for 22 hours, and then analyzed using ELISA.
Fig 4
Fig 4
Inhibitory effect of S. cerevisiae-derived vacuoles on mRNA expression levels of (A) iNOS, (B) COX-2, (C) TNF-α, and (D) IL-6 in RAW 264.7 cells stimulated by LPS. The cells were stimulated with 1 µg/mL LPS for 2 hours, followed by treatment with dexamethasone or vacuoles for 22 hours. The mRNA levels were measured using reverse transcription quantitative PCR (RT-qPCR). The gene expression levels were normalized to the expression of the housekeeping gene GAPDH.
Fig 5
Fig 5
Effect of S. cerevise-derived vacuoles on the translocation of NF-κB p65 in LPS-stimulated RAW 264.7 cells. Cells were stimulated with 1 µg/mL LPS, and the nuclear and cytoplasmic localization of p65 was evaluated using an NF-κB p65 monoclonal antibody, a goat anti-rabbit IgG H&L antibody (green), and DAPI nuclear stain (blue). Scale bar = 10 µM.

Similar articles

Cited by

References

    1. Feldmann H. 2012. In Yeast: molecular and cell biology. John Wiley & Sons. doi:10.1002/9783527659180 - DOI
    1. Baba M, Osumi M, Scott SV, Klionsky DJ, Ohsumi Y. 1997. Two distinct pathways for targeting proteins from the cytoplasm to the vacuole/lysosome. J Cell Biol 139:1687–1695. doi:10.1083/jcb.139.7.1687 - DOI - PMC - PubMed
    1. Kornfeld S. 1987. Trafficking of lysosomal enzymes 1. FASEB J. 1:462–468. doi:10.1096/fasebj.1.6.3315809 - DOI - PubMed
    1. von Figura K, Hasilik A. 1986. Lysosomal enzymes and their receptors. Annu Rev Biochem 55:167–193. doi:10.1146/annurev.bi.55.070186.001123 - DOI - PubMed
    1. Thumm M. 2000. Structure and function of the yeast vacuole and its role in autophagy. Microsc Res Tech 51:563–572. doi:10.1002/1097-0029(20001215)51:6<563::AID-JEMT6>3.0.CO;2-8 - DOI - PubMed

LinkOut - more resources